Skip to content

Clinical trials

Recruiting Lung Diseases, Interstitial trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Status: Recruiting Country / region: China Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20211
20233
20246
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Ruijin Hospital2
Boehringer Ingelheim1
Children's Hospital of Fudan University1
China-Japan Friendship Hospital1
ChromX Health1
Dai Huaping1
Guang'anmen Hospital of China Academy of Chinese Medical Sciences1
Henan University of Traditional Chinese Medicine1
Huilan Zhang1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial19
Connective Tissue Diseases3
Lung Diseases2
Scleroderma, Diffuse2
Sjogren's Syndrome2
Amyloidosis1
Arthritis, Rheumatoid1
Asthma1
Autoimmune Diseases1
Bronchiectasis1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.